Site icon Kush.com Blog

CBD vs CBL: Unveiling the Mysteries

CBD (Cannabidiol) and CBL (Cannabicyclol) captivate the attention of scientists and wellness enthusiasts alike as members of the compelling cannabinoid family found in hemp and cannabis plants. These cannabinoids, although sharing a familial bond, diverge intriguingly in their characteristics and impacts on the human body.

CBD, widely recognized and researched, stands out for its non-psychoactive nature, ensuring users do not experience the notorious “high” associated with certain cannabinoids. It engages with the body’s intricate endocannabinoid system, orchestrating a symphony of receptors that govern various physiological functions.

In contrast, CBL, a cannabinoid shrouded in mystery, remains non-psychoactive yet is sparsely found in most cannabis strains. Its formation, a result of the degradation of Cannabichromene (CBC) under the influence of light or heat, presents a unique developmental pathway among cannabinoids.

Despite being under the same cannabinoid umbrella, CBD and CBL differ markedly in their prevalence, endocannabinoid system interactions, and formation processes. To unravel the potentialities and applications of these cannabinoids, further research is imperative.

Many States allow hemp derived cannabinoids under the 2018 Farm Bill as long as they contain less than .3% D9 THC. Some States have explicitly banned cannabinoids like Delta 8, so check your local rules and regulations before purchasing.

Here’s the rules for Kush.com and more details

Frequently Asked Questions (FAQs)

Shop

Similar Product Searches You Might Be Interested In:

Exit mobile version